EE+ POEM Archive
In patients with HF-pEF, obesity, and no diabetes, semaglutide causes weight loss, symptom improvement, and fewer cardiac events (STEP-HFpEF)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "In Patients With HF-pEF, Obesity, and No Diabetes, Semaglutide Causes Weight Loss, Symptom Improvement, and Fewer Cardiac Events (STEP-HFpEF)." EE+ POEM Archive, John Wiley & Sons, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315976/all/In_patients_with_HF_pEF__obesity__and_no_diabetes__semaglutide_causes_weight_loss__symptom_improvement__and_fewer_cardiac_events__STEP_HFpEF_.
In patients with HF-pEF, obesity, and no diabetes, semaglutide causes weight loss, symptom improvement, and fewer cardiac events (STEP-HFpEF). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2024. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315976/all/In_patients_with_HF_pEF__obesity__and_no_diabetes__semaglutide_causes_weight_loss__symptom_improvement__and_fewer_cardiac_events__STEP_HFpEF_. Accessed December 5, 2024.
In patients with HF-pEF, obesity, and no diabetes, semaglutide causes weight loss, symptom improvement, and fewer cardiac events (STEP-HFpEF). (2024). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315976/all/In_patients_with_HF_pEF__obesity__and_no_diabetes__semaglutide_causes_weight_loss__symptom_improvement__and_fewer_cardiac_events__STEP_HFpEF_
In Patients With HF-pEF, Obesity, and No Diabetes, Semaglutide Causes Weight Loss, Symptom Improvement, and Fewer Cardiac Events (STEP-HFpEF) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2024. [cited 2024 December 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315976/all/In_patients_with_HF_pEF__obesity__and_no_diabetes__semaglutide_causes_weight_loss__symptom_improvement__and_fewer_cardiac_events__STEP_HFpEF_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - In patients with HF-pEF, obesity, and no diabetes, semaglutide causes weight loss, symptom improvement, and fewer cardiac events (STEP-HFpEF)
ID - 1315976
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315976/all/In_patients_with_HF_pEF__obesity__and_no_diabetes__semaglutide_causes_weight_loss__symptom_improvement__and_fewer_cardiac_events__STEP_HFpEF_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
